RxSource Announces Major U.S. Expansion with New Jersey, West Deptford Facility Move

RxSource, a Canadian-headquartered leader in clinical trial supply services, is proud to announce a significant expansion of its U.S. operations. The company will relocate from its current site in Secaucus, New Jersey, to a substantially larger facility in West Deptford. This move will increase RxSource’s U.S. operational footprint to over 48,000 sq.ft, significantly boosting capacity to meet rising client demand and creating numerous job opportunities in the local community.

In the coming weeks, RxSource will begin outfitting the West Deptford facility with advanced infrastructure, including specialized cold chain packaging and labeling rooms. The new facility is projected to be fully operational by late 2024, with new job listings to be announced shortly.

Yussuf Goolam, CEO of RxSource, remarked, “This expansion is a monumental milestone for RxSource. It underscores our commitment to excellence and reflects the hard work and dedication of our global team. Our client’s increased demand has driven us to this exciting phase of growth, and we are thrilled to invest in a facility that will support our ambitious future.  Together, with the strength of our team, our clients, our vendors, and stakeholders this facility will allow us to achieve our purpose to Improve the Lives of Patients.”

Rhys Evans, Senior Vice President of Global Operations, added, “The launch of our new facility marks a pivotal moment for RxSource. The upcoming fit-out will dramatically enhance our capacity with additional temperature-controlled services.  Situated within a prime pharmaceutical and distribution hub, this facility offers unparalleled opportunities for future expansion, ensuring we are exceptionally well-positioned for continued growth.”

About RxSource 

RxSource is at the forefront of providing clinical trial supply services to the global pharmaceutical and biotech sectors. We are dedicated to ensuring exceptional

service and value for our client’s projects every step of the way.

Our extensive portfolio of services includes packaging and labeling clinical trial supplies under stringent temperature-controlled conditions (ambient, refrigerated, and frozen), sourcing commercial products (comparators, co-medications, rescue medications, and ancillaries), and reverse logistics.

We also offer global temperature-controlled distribution from our North American and EU facilities, supported by a robust network of partner depots. Additional services include Importer of Record and Qualified Person (QP) release services in the EU, along with expert consultation on compliant and tax-efficient movement of clinical trial medications.

Our commitment to excellence, coupled with our proactive approach, experienced team, flexible capacity planning, and Purpose to Improve the Lives of 10 million patients, sets us apart in the industry.